Cargando…
Glymphatic System and Subsidiary Pathways Drive Nanoparticles Away from the Brain
Although drug delivery systems (DDS) are efficient in brain delivery, they face failure in clinical settings due to their potential toxicity to the central nervous system. Little is known about where the DDS will go after brain delivery, and no specific elimination route that shares a passage with D...
Autores principales: | Liu, Rui, Jia, Wenfeng, Wang, Yushan, Hu, Chuan, Yu, Wenqi, Huang, Yuan, Wang, Ling, Gao, Huile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AAAS
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943630/ https://www.ncbi.nlm.nih.gov/pubmed/35360646 http://dx.doi.org/10.34133/2022/9847612 |
Ejemplares similares
-
Dual-responsive nanoparticles with transformable shape and reversible charge for amplified chemo-photodynamic therapy of breast cancer
por: Jia, Wenfeng, et al.
Publicado: (2022) -
Glymphatic pathways in the gyrencephalic brain
por: Bèchet, Nicholas Burdon, et al.
Publicado: (2021) -
Subsidiary closures and relocations in the multinational enterprise: Reinstating cooperation in subsidiaries to enable knowledge transfer
por: Reilly, Marty, et al.
Publicado: (2023) -
Multinational Corporation Subsidiaries in China
por: Zhao, Jinghua
Publicado: (2012) -
Maize LOST SUBSIDIARY CELL encoding a large subunit of ribonucleotide reductase is required for subsidiary cell development and plant growth
por: Cui, Yongqi, et al.
Publicado: (2023)